Finance

Lists
ADUS:NASDAQ
Addus Homecare Corporation
$117.07
-0.84%
(-0.99) 1D
$117.07
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADUS...
Open
$117.75
High
$117.75
Low
$115.12
Mkt. cap
2.19B
Avg. vol.
192.81K
Volume
590.71K
P/E ratio
20.52
52-wk high
$124.44
52-wk low
$87.95
EPS
$5.71
Beta
0.86
Shares outstanding
18.67M
No. of employees
28K
Open
$117.75
High
$117.75
Low
$115.12
Mkt. cap
2.19B
Avg. vol.
192.81K
Volume
590.71K
P/E ratio
20.52
52-wk high
$124.44
52-wk low
$87.95
EPS
$5.71
Beta
0.86
Shares outstanding
18.67M
No. of employees
28K
News stories
From web sources and news partners
About Addus Homecare Corporation
CEOR. Dirk Allison
Employees28.3K
Founded1979
HeadquartersFrisco, Texas, United States
SectorHealth care provider
Websiteaddus.com
Analyst ratings
Based on 9 analysts giving stock ratings to ADUS in the past 3 months
Buy
Buy
6
Hold
2
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ADUS in the last 3 months.
Highest
Current $117.07
$145.00 (+23.86%)
Average
$126.00 (+7.63%)
Lowest
$96.00 (-18.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Clarke Murphy
Truist Financial
Buy
Maintained
-
-
09/15/2026
Jared Haase
William Blair
Buy
Maintained
-
-
09/14/2026
Joanna Gajuk
Bank of America Securities
Hold
Downgraded
$125.00
+6.8%
09/14/2026
Sean Dodge
BMO Capital
Hold
Maintained
$115.00
-1.8%
09/02/2026
Andrew Mok CFA
Barclays
Sell
Maintained
$96.00
-18%
08/28/2026
Unknown Analyst
Stephens
Buy
Maintained
$136.00
+16.2%
08/05/2026
Raj Kumar CFA
Stephens
Buy
Maintained
$136.00
+16.2%
08/05/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$134.00
+14.5%
08/05/2026
Ryan Langston
TD Cowen
Buy
Reiterated
$131.00
+11.9%
08/04/2026
A.J. Rice
UBS
Buy
Maintained
$145.00
+23.9%
06/24/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$142.00
+21.3%
05/06/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
05/07/2026
John Ransom
Raymond James
Buy
Maintained
-
-
05/06/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$155.00
+32.4%
05/06/2026
Jim Salera
Stephens
Buy
Reiterated
$135.00
+15.3%
02/25/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.73 / $1.70
+1.87%beat
Revenue / Est. (USD)
377.42M / 376.22M
+0.32%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
362.30M
373.08M
363.61M
377.42M
Cost of goods sold
245.59M
249.47M
247.74M
258.26M
Cost of revenue
245.59M
249.47M
247.74M
258.26M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77.87M
77.48M
77.77M
78.49M
Operating expense
82.28M
81.63M
81.80M
82.62M
Total operating expenses
327.86M
331.10M
329.54M
340.88M
Operating income
34.44M
41.98M
34.07M
36.54M
Other non operating income
-
-
-
-
EBT including unusual items
30.35M
40.15M
32.43M
37.78M
EBT excluding unusual items
31.85M
39.85M
32.43M
35.38M
Income tax expense
7.51M
10.37M
7.36M
10.18M
Effective tax rate
24.73%
25.82%
22.70%
26.93%
Other operating expenses
-
-
-
-
Net income
22.85M
29.78M
25.07M
27.61M
Net profit margin
6.31%
7.98%
6.89%
7.31%
Earnings per share
1.56
1.77
1.62
1.73
Interest and investment income
760.00K
597.00K
510.00K
566.00K
Interest expense
-3.34M
-2.73M
-2.15M
-1.72M
Net interest expenses
-2.58M
-2.13M
-1.64M
-1.16M
Depreciation and amortization charges
4.41M
4.15M
4.03M
4.12M
EBITDA
38.84M
46.12M
38.10M
40.67M
Gain or loss from assets sale
2.00K
4.00K
-16.00K
3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps